BOX vs CLBT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a lack of Altman Z-Score raises concerns about bankruptcy risk assessment. Despite strong gross margins and solid historical earnings surprises, the company is experiencing sharply declining earnings (YoY EPS growth of -88.9%) and negative technical momentum. High debt levels (Debt/Equity: 3.61) and insider selling activity further undermine confidence, while the stock trades above its intrinsic value estimate of $8.68 at a current price of $26.48. Although revenue growth remains positive and profitability metrics like ROE are elevated, these are offset by deteriorating cash flow trends and aggressive insider selling, particularly from top executives.
CLBT shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 7/9). Key strengths include strong valuation and growth metrics. Price trades at a 370.1% premium to fair value estimate ($3.01), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BOX vs CLBT: Head-to-Head Comparison
This page compares Box, Inc. (BOX) and Cellebrite DI Ltd. (CLBT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.